News from the Board

Chevy Chase, MD – March 26, 2020 – The International Lyme and Associated Diseases Society (ILADS) is launching a new registry and crowd-solving platform, One Health Lyme, which will provide valuable resources to healthcare providers who are treating patients with Lyme and related diseases. In the planning stages for a while, the launch of the…

FOR IMMEDIATE RELEASE The International Lyme and Associated Diseases Society (ILADS) announced that their paper “Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group” has been published in the journal “Antibiotics” as part of the special issue “Antibiotics Resistance of Borrelia.” The authors of the paper are Dr. Samuel Shor, Dr. Christine Green,…

The controversy over the existence of chronic Lyme disease and the best methods for treating it continues. In June 2017, a group of doctors published a MMWR report about possible risks of long-term antibiotics in treating Lyme. ILADS Past President Samuel Shor published a response on PubMed Commons to outline ILADS concerns with the methodology and conclusions of the report.